Vaxxinity, Inc. (VAXX)
USD 0.0
(100.0%)
USD 0.0
(100.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -57.23 Million | -55.92 Million | -80.99 Million | -33.91 Million | -12.26 Million |
| Net Income | -56.93 Million | -75.22 Million | -137.17 Million | -39.95 Million | -14.21 Million |
| Depreciation & Amortization | 2.23 Million | 1.68 Million | 1.1 Million | 717 Thousand | 107 Thousand |
| Deferred income taxes | -15.48 Million | - | 8.57 Million | 656 Thousand | - |
| Stock-based compensation | 7.5 Million | 8.71 Million | 30.41 Million | 1.01 Million | 1.22 Million |
| Change in working capital | -8.54 Million | 9.82 Million | 12.88 Million | -2.79 Million | 157 Thousand |
| Other non-cash items | 13.98 Million | -926 Thousand | 3.2 Million | 6.45 Million | 462 Thousand |
| Investing Cash Flow | 28.84 Million | -54.39 Million | -1.31 Million | -1.47 Million | - |
| Investments in PPE | -803 Thousand | -1.86 Million | -1.31 Million | -1.47 Million | - |
| Acquisitions | -29.64 Thousand | 52.52 Million | - | - | - |
| Investment purchases | -63.94 Million | -107.52 Million | - | - | - |
| Sales/Maturities of investments | 93.58 Million | 55 Million | - | - | - |
| Other Investing Activities | 29.64 Thousand | -52.52 Million | - | - | - |
| Financing Cash Flow | -1.14 Million | -167 Thousand | 196.16 Million | 66.1 Million | 11.13 Million |
| Debt repayment | -1.59 Million | -430 Thousand | -2.77 Million | -5.7 Million | -11.12 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -41 Thousand | - |
| Common Stock Issuance | 454 Thousand | 263 Thousand | 71.07 Million | 59.81 Million | 17 Thousand |
| Other Financing Activities | 454.00 | -167 Thousand | 127.86 Million | 71.85 Million | 22.24 Million |
| Accounts receivables | -1000.00 | -21 Thousand | 26 Thousand | -26 Thousand | -146 Thousand |
| Accounts payables | -3.51 Million | 2.1 Million | 2.17 Million | -267 Thousand | -446 Thousand |
| Inventory | - | 21 Thousand | 8.43 Million | -244 Thousand | 146 Thousand |
| Other working capital | -5.03 Million | 7.71 Million | 2.25 Million | -2.25 Million | 603 Thousand |
| Cash at beginning of period | 34.57 Million | 145.05 Million | 31.19 Million | 476 Thousand | 1.6 Million |
| Cash at end of period | 5.03 Million | 34.57 Million | 145.05 Million | 31.19 Million | 476 Thousand |
| Capital Expenditure | -803 Thousand | -1.86 Million | -1.31 Million | -1.47 Million | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -29.53 Million | -110.48 Million | 113.85 Million | 30.72 Million | -1.12 Million |
| Free Cash Flow | -58.04 Million | -57.79 Million | -82.3 Million | -35.38 Million | -12.26 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.39 Million | -56.93 Million | -13.14 Million | -13.97 Million | -18.42 Million | -20.45 Million |
| Depreciation & Amortization | 456 Thousand | 2.23 Million | 666 Thousand | 526 Thousand | 586 Thousand | 540 Thousand |
| Deferred income taxes | -2.93 Million | -15.48 Million | -350 Thousand | -872 Thousand | - | - |
| Stock-based compensation | 1.08 Million | 7.5 Million | 1.76 Million | 2.43 Million | 2.22 Million | 2.35 Million |
| Change in working capital | -1.67 Million | -8.54 Million | -2.13 Million | -687 Thousand | -4.04 Million | 3.63 Million |
| Other non-cash items | 2.61 Million | 13.98 Million | 13 Thousand | 419 Thousand | -393 Thousand | -544 Thousand |
| Investing Cash Flow | -407 Thousand | 28.84 Million | -6.09 Million | 26.61 Million | 8.74 Million | 27.2 Million |
| Investments in PPE | -414 Thousand | -803 Thousand | -127 Thousand | -90 Thousand | -172 Thousand | -292 Thousand |
| Acquisitions | -7.00 | -29.64 Thousand | 5.97 Million | - | -8.91 Million | - |
| Investment purchases | -20.35 Million | -63.94 Million | -24.99 Million | - | -18.58 Million | - |
| Sales/Maturities of investments | 20.36 Million | 93.58 Million | 19.02 Million | 26.7 Million | 27.5 Million | 27.5 Million |
| Other Investing Activities | 7.00 | 29.64 Thousand | -5.97 Million | 26.7 Thousand | 8.91 Million | 27.5 Thousand |
| Financing Cash Flow | -313 Thousand | -1.14 Million | -379 Thousand | 126 Thousand | -574 Thousand | -109 Thousand |
| Debt repayment | -314 Thousand | -1.59 Million | -435 Thousand | -268 Thousand | -577 Thousand | -110 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1000.00 | 454 Thousand | 56 Thousand | 393 Thousand | 4000.00 | 1000.00 |
| Other Financing Activities | 1.00 | 454.00 | -379 Thousand | 1000.00 | -1000.00 | -109 Thousand |
| Accounts receivables | -8000.00 | -1000.00 | - | 111 Thousand | -104 Thousand | 2.71 Million |
| Accounts payables | -931 Thousand | -3.51 Million | 1.08 Million | -1.14 Million | -2.26 Million | 1.97 Million |
| Inventory | - | - | - | -111 Thousand | 104 Thousand | -2.71 Million |
| Other working capital | -731 Thousand | -5.03 Million | -3.21 Million | 455 Thousand | -1.78 Million | 1.65 Million |
| Cash at beginning of period | 17.6 Million | 34.57 Million | 37.26 Million | 22.68 Million | 34.57 Million | 21.94 Million |
| Cash at end of period | 5.03 Million | 5.03 Million | 17.6 Million | 37.26 Million | 22.68 Million | 34.57 Million |
| Capital Expenditure | -414 Thousand | -803 Thousand | -127 Thousand | -90 Thousand | -172 Thousand | -292 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -12.56 Million | -29.53 Million | -19.66 Million | 14.57 Million | -11.88 Million | 12.62 Million |
| Free Cash Flow | -12.25 Million | -58.04 Million | -13.31 Million | -12.24 Million | -20.22 Million | -14.76 Million |
1851
BEM
CDLR
9405
IVCGF
DALBHARAT